Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$620,000 |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$314M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| CHILDS JOHN W | Dec 30, 2024 | Buy | 29,000 | $35.9446 | $1M |
| CHILDS JOHN W | Oct 2, 2024 | Buy | 21,052 | $47.5 | $1,000,000 |
| Coric Vlad | Oct 2, 2024 | Buy | 21,052 | $47.5 | $1,000,000 |
| Bailey Gregory | Sep 24, 2024 | Buy | 5,000 | $44.1932 | $220,000 |
| CHILDS JOHN W | Jul 18, 2024 | Buy | 28,400 | $35.6684 | $1M |
| Car Bruce | Jun 17, 2024 | Buy | 30,000 | $33.583 | $1M |
| CHILDS JOHN W | May 30, 2024 | Buy | 28,000 | $35.58 | $1,000,000 |
| Bailey Gregory | May 13, 2024 | Buy | 15,000 | $34.1918 | $510,000 |
| CHILDS JOHN W | May 13, 2024 | Buy | 28,500 | $35.1744 | $1M |
| Bailey Gregory | Apr 24, 2024 | Buy | 25,503 | $39.1785 | $1,000,000 |
| Coric Vlad | Apr 22, 2024 | Buy | 121,951 | $41 | $5M |
| Bailey Gregory | Apr 22, 2024 | Buy | 48,780 | $41 | $2M |
| CHILDS JOHN W | Apr 22, 2024 | Buy | 97,560 | $41 | $4M |
| CHILDS JOHN W | Apr 22, 2024 | Buy | 73,170 | $41 | $3M |
| CHILDS JOHN W | Apr 22, 2024 | Buy | 24,391 | $41 | $1M |
| Antonijevic Irina | Dec 29, 2023 | Sell | 11,000 | $41.7875 | $460,000 |
| CHILDS JOHN W | Oct 5, 2023 | Buy | 318,000 | $22 | $7M |
| CHILDS JOHN W | Oct 5, 2023 | Buy | 136,545 | $22 | $3M |
| Coric Vlad | Oct 5, 2023 | Buy | 340,908 | $22 | $7.5M |
| Coric Vlad | Oct 5, 2023 | Buy | 113,637 | $22 | $2.5M |
| Buten Matthew | Oct 5, 2023 | Buy | 22,727 | $22 | $500,000 |
| Bailey Gregory | Oct 4, 2023 | Buy | 17,817 | $22.568 | $400,000 |
| CHILDS JOHN W | Aug 30, 2023 | Buy | 50,000 | $18.4436 | $920,000 |
| CHILDS JOHN W | Aug 4, 2023 | Buy | 100,000 | $19.7843 | $2M |
What's the latest insider transaction for Biohaven?
The most recent insider transaction for Biohaven was conducted by CHILDS JOHN W, who sold 29,000 shares on December 30, 2024 at a price of $35.94 per share.
Which insider bought the most BHVN stock over the last two years?
CHILDS JOHN W has bought the most BHVN stock in the last 2 years, with a total value of $26M.
Which insider has sold the most BHVN stock over the last two years?
Antonijevic Irina has sold the most BHVN stock in the last 2 years, with a total value of $460,000.
What is the total value of insider transactions for Biohaven (BHVN) in the last 2 years?
According to our estimates, the total value of insider transactions for Biohaven in the last 2 years is positive, amounting to $47M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Biohaven's market confidence?
Over the last 2 years, insider transactions for Biohaven have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
